Illinois HB5492 mandates coverage for up to a 12-month supply of prescription hormone therapy in health insurance policies.
Illinois HB5492 amends the Illinois Insurance Code, the Pharmacy Practice Act, the State Employees Group Insurance Act of 1971, and the Illinois Public Aid Code to require coverage for up to a 12-month supply of prescription hormone therapy in health insurance policies. This applies to policies amended, delivered, issued, or renewed on or after January 1, 2028. The bill defines "prescription hormone therapy" as drugs used to medically suppress, increase, or replace hormones and excludes glucagon-like peptide-1 and its receptor agonists.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.